Kevin Lee - Sep 1, 2021 Form 4 Insider Report for BICYCLE THERAPEUTICS plc (BCYC)

Role
Chief Executive Officer, Director
Signature
/s/ Lee Kalowski, Attorney-in-Fact
Stock symbol
BCYC
Transactions as of
Sep 1, 2021
Transactions value $
-$887,437
Form type
4
Date filed
9/3/2021, 04:46 PM
Previous filing
Aug 31, 2021
Next filing
Oct 13, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCYC Ordinary Shares Options Exercise $320K +22.9K +9.37% $14.00 267K Sep 1, 2021 Direct
transaction BCYC Ordinary Shares Sale -$298K -8.19K -3.07% $36.38 259K Sep 1, 2021 Direct F1, F2
transaction BCYC Ordinary Shares Sale -$642K -17.1K -6.6% $37.52 242K Sep 1, 2021 Direct F1, F3
transaction BCYC Ordinary Shares Sale -$68.4K -1.8K -0.74% $38.08 240K Sep 1, 2021 Direct F1, F4
transaction BCYC Ordinary Shares Sale -$200K -5K -2.08% $40.00 235K Sep 2, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCYC Stock Option (right to buy) Options Exercise $0 -22.9K -6.95% $0.00 306K Sep 1, 2021 Ordinary Shares 22.9K $14.00 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 trading plan.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.975 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4).
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.99 inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.00 to $38.255 inclusive.
F5 This option shall vest in 36 equal monthly installments at the end of each calendar month following the date of the grant.